Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Early prosocial behavior good predictor of kids' future

  • Science educators analyze genetics content of Next Generation Science Standards

  • Study of 'senior citizen' marine snails uncovered how nerve cells fail during learning

  • Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma

  • Naturally occurring protein fragment found in the brain inhibits key enzyme implicated in Alzheimer's disease

  • Ongoing recovery efforts take toll on hurricane survivors

  • Climbing a tree can improve cognitive skills, researchers say

  • Socially integrated women have lower suicide risk

  • Key factor for stability of capillaries in brain identified

  • Mechanism behind the lack of effectiveness of certain antagonist drugs discovered

  •